Revolutionary Radiation Treatment Offers Hope for Patients With ...
Oct 25, 2024 · Tufts Medicine brings a next-generation treatment for advanced prostate cancer that offers new hope for patients whose cancer has spread and no longer responds to hormone therapy or docetaxel chemotherapy.
A Promising New Therapy for Advanced Prostate Cancer
Jun 3, 2021 · Prostate cancer treatment stands on the brink of a major advance with the development of a new treatment that zeros in on cancer cells to destroy them. The therapy, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface.
FDA Approves Promising Therapy for Advanced Prostate Cancer: …
Mar 23, 2022 · Prostate cancer treatment took a major step forward today as the U.S. Food and Drug Administration approved a new therapy that zeros in on cancer cells to destroy them. The treatment, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface called PSMA (prostate-specific ...
FDA Approves Relugolix for Advanced Prostate Cancer
Jan 26, 2021 · In a large clinical trial, the drug, relugolix (Orgovyx), was shown to be more effective at reducing testosterone levels in men with advanced prostate cancer than another commonly used treatment, leuprolide (Lupron).
Xtandi Approved for High-Risk Prostate Cancer - NCI
Jan 5, 2024 · With the expanded approval of enzalutamide (Xtandi), oncologists have a new treatment option to offer some patients with prostate cancer who have had a biochemical recurrence.
FDA approves new treatment for advanced prostate cancer
Jul 12, 2023 · In June, the FDA approved a new treatment for the most advanced type of prostate cancer. Patients who have this condition, which is called metastatic castration-resistant prostate cancer (mCRPC), have few therapeutic options, so the approval helps to fill an urgent need.
(Video) New hope for patients with metastatic prostate cancer
Sep 5, 2024 · Mayo Clinic is leading the way with a new treatment for advanced prostate cancer, specifically for prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC). This treatment involves a …
FDA Fast Tracks New Treatment For Advanced Prostate Cancer
Sep 6, 2024 · After prostate cancer has spread (or metastasized), the five-year survival rate drops to 36%. But a new treatment may help change this – and it’s on the fast-track for approval by the Food and Drug Administration (FDA). The drug, Biontech’s BNT324/DB-1311, is …
Talazoparib Combo Approved for Metastatic Prostate Cancer
Aug 4, 2023 · The Food and Drug Administration (FDA) has approved the combination of enzalutamide (Xtandi) with talazoparib (Talzenna) as an initial treatment for some people with metastatic castration-resistant prostate cancer.
A new treatment for advanced prostate cancer improves survival …
Jul 12, 2021 · One of these new therapies is now generating promising data for men with the most aggressive prostate cancer. Radiation therapy is getting more precise, making it easier to kill tumors while sparing their surrounding tissues.